This activity allows companies to present their noteworthy new products and services through live presentations. Seating is available on a first-come, first-served basis. The Industry-Expert Theater content and views expressed therein are those of the companies and not of ASTRO.
Lunch or other food and beverages may be provided by the companies, which may subject you to reporting under the Federal Sunshine Act (the Open Payments Program) or other state laws.
Grand Canyon 4-5
5:30 p.m. - 6:30 p.m. | Coherus
Advances in the Treatment of Recurrent Locally Advanced/Metastatic (R/M) Nasopharyngeal Carcinoma (NPC) with LOQTORZI⢠(toripalimab-tpzi)
Contact: Amy Dolnick
Email: adolnick@coherus.com
Grand Canyon 9-10
5:30 p.m. - 7:00 p.m. | Naveris, Inc.
Action to Insights: A Case-Based Discussion of the Role of NavDx in Post-treatment Surveillance of HPV-Driven OPSCC
Contact: Julie Wojda
Email: jwojda44@gmail.com
Grand Canyon 4-5
5:30 p.m. - 6:30 p.m. | Merck
Advance Your Knowledge of a Treatment Option for Head and Neck Squamous Cell Carcinoma (HNSCC)
Contact: Jessica Lutton
Email: jessica.lutton@merck.com
Grand Canyon 9-10
5:30 p.m. - 6:30 p.m. | Regeneron
Co-Managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era
Contact: Alexis Hammond
Email: alexis.hammond@syneoshealth.com
